MaxCyte (MXCT)
(Delayed Data from NSDQ)
$4.64 USD
-0.27 (-5.50%)
Updated Jan 14, 2025 04:00 PM ET
After-Market: $4.65 +0.01 (0.22%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/11/25 |
---|---|
Current Quarter | -0.14 |
EPS Last Quarter | -0.11 |
Last EPS Surprise | 15.38% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.42 |
Next Year | -0.41 |
EPS (TTM) | -0.34 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 10.30M | NA | 46.10M |
# of Estimates | NA | 1 | NA | 2 |
High Estimate | NA | 10.30M | NA | 47.40M |
Low Estimate | NA | 10.30M | NA | 44.80M |
Year ago Sales | 15.67M | 11.34M | 41.29M | NA |
Year over Year Growth Est. | NA | -9.17% | NA | NA |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.14 | -0.13 | -0.42 | -0.41 |
# of Estimates | 2 | 1 | 3 | 3 |
Most Recent Consensus | -0.15 | -0.13 | -0.43 | -0.46 |
High Estimate | -0.12 | -0.13 | -0.41 | -0.34 |
Low Estimate | -0.15 | -0.13 | -0.43 | -0.46 |
Year ago EPS | -0.05 | -0.09 | -0.37 | -0.42 |
Year over Year Growth Est. | -180.00% | -44.44% | -13.51% | 0.80% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.14 | -0.13 | -0.42 | -0.41 |
7 Days Ago | -0.14 | -0.13 | -0.42 | -0.41 |
30 Days Ago | -0.14 | -0.13 | -0.42 | -0.41 |
60 Days Ago | -0.14 | -0.13 | -0.43 | -0.42 |
90 Days Ago | -0.13 | -0.13 | -0.44 | -0.42 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.14 | -0.13 | -0.42 | -0.41 |
Zacks Consensus Estimate | -0.14 | -0.13 | -0.42 | -0.41 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.11 | -0.09 | -0.09 | -0.05 | NA |
Estimate | -0.13 | -0.14 | -0.14 | -0.10 | NA |
Difference | 0.02 | 0.05 | 0.05 | 0.05 | 0.04 |
Surprise | 15.38% | 35.71% | 35.71% | 50.00% | 34.20% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more